Albumin Behring 200 g/l infuusioneste, liuos Finska - finščina - Fimea (Suomen lääkevirasto)

albumin behring 200 g/l infuusioneste, liuos

csl behring gmbh - albumin, human - infuusioneste, liuos - 200 g/l - albumiini

Multibic Kalium 3 mmol/l hemodialyysi- / hemofiltraationeste Finska - finščina - Fimea (Suomen lääkevirasto)

multibic kalium 3 mmol/l hemodialyysi- / hemofiltraationeste

fresenius medical care deutschland gmbh - calcium chloride dihydrate, glucose monohydrate, potassium chloride, magnesium chloride hexahydrate, sodium chloride, sodium hydrogen carbonate - hemodialyysi- / hemofiltraationeste - 3 mmol/l - hemofiltraatit

BICANOVA 2.3 % GLUKOOSI peritoneaalidialyysineste Finska - finščina - Fimea (Suomen lääkevirasto)

bicanova 2.3 % glukoosi peritoneaalidialyysineste

fresenius medical care deutschland gmbh - glucosum monohydricum,magnesii chloridum hexahydricum,calcii chloridum dihydricum,natrii hydrogenocarbonas,natrii chloridum - peritoneaalidialyysineste - hypertoniset liuokset

BICANOVA 4.25 % GLUKOOSI peritoneaalidialyysineste Finska - finščina - Fimea (Suomen lääkevirasto)

bicanova 4.25 % glukoosi peritoneaalidialyysineste

fresenius medical care deutschland gmbh - magnesium chloridum hexahydricum,natrii chloridum,kalsiumia chloridum dihydricum,glukoosi monohydricum,natrii hydrogenocarbonas - peritoneaalidialyysineste - hypertoniset liuokset

Tyenne Evropska unija - finščina - EMA (European Medicines Agency)

tyenne

fresenius kabi deutschland gmbh - tosilitsumabin - arthritis, rheumatoid; cytokine release syndrome; arthritis, juvenile rheumatoid; covid-19 virus infection; giant cell arteritis - immunosuppressantit - tyenne, in combination with methotrexate (mtx), is indicated for- the treatment of severe, active and progressive rheumatoid arthritis (ra) in adults not previously treated with mtx. - the treatment of moderate to severe active ra in adult patients who have either responded inadequately to, or who were intolerant to, previous therapy with one or more disease-modifying anti-rheumatic drugs (dmards) or tumour necrosis factor (tnf) antagonists. in these patients, tyenne can be given as monotherapy in case of intolerance to mtx or where continued treatment with mtx is inappropriate. tocilizumab has been shown to reduce the rate of progression of joint damage as measured by x-ray and to improve physical function when given in combination with methotrexate. tyenne is indicated for the treatment of coronavirus disease 2019 (covid-19) in adults who are receiving systemic corticosteroids and require supplemental oxygen or mechanical ventilation. tyenne is indicated for the treatment of active systemic juvenile idiopathic arthritis (sjia) in patients 1 year of age and older, who have responded inadequately to previous therapy with nsaids and systemic corticosteroids. tyenne can be given as monotherapy (in case of intolerance to mtx or where treatment with mtx is inappropriate) or in combination with mtx. tyenne in combination with methotrexate (mtx) is indicated for the treatment of juvenile idiopathic polyarthritis (pjia; rheumatoid factor positive or negative and extended oligoarthritis) in patients 2 years of age and older, who have responded inadequately to previous therapy with mtx. tyenne can be given as monotherapy in case of intolerance to mtx or where continued treatment with mtx is inappropriate. tyenne is indicated for the treatment of chimeric antigen receptor (car) t cell-induced severe or life-threatening cytokine release syndrome (crs) in adults and paediatric patients 2 years of age and older. tyenne is indicated for the treatment of giant cell arteritis (gca) in adult patients.

Bicavera 1.5 % Glukoosi, 1.75 Mmol/L Kalsium peritoneaalidialyysineste Finska - finščina - Fimea (Suomen lääkevirasto)

bicavera 1.5 % glukoosi, 1.75 mmol/l kalsium peritoneaalidialyysineste

fresenius medical care deutschland gmbh - magnesium chloride hexahydrate, sodium hydrogen carbonate, glucose monohydrate, sodium chloride, calcium chloride - peritoneaalidialyysineste - hypertoniset liuokset

Bicavera 4.25 % Glukoosi, 1.75 Mmol/L Kalsium peritoneaalidialyysineste Finska - finščina - Fimea (Suomen lääkevirasto)

bicavera 4.25 % glukoosi, 1.75 mmol/l kalsium peritoneaalidialyysineste

fresenius medical care deutschland gmbh - sodium hydrogen carbonate, magnesium chloride hexahydrate, glucose monohydrate, sodium chloride, calcium chloride - peritoneaalidialyysineste - hypertoniset liuokset

Bicavera 2.3 % Glukoosi, 1.75 Mmol/L Kalsium peritoneaalidialyysineste Finska - finščina - Fimea (Suomen lääkevirasto)

bicavera 2.3 % glukoosi, 1.75 mmol/l kalsium peritoneaalidialyysineste

fresenius medical care deutschland gmbh - magnesium chloride hexahydrate, sodium hydrogen carbonate, glucose monohydrate, sodium chloride, calcium chloride - peritoneaalidialyysineste - hypertoniset liuokset

BICANOVA 1.5 % GLUKOOSI peritoneaalidialyysineste Finska - finščina - Fimea (Suomen lääkevirasto)

bicanova 1.5 % glukoosi peritoneaalidialyysineste

fresenius medical care deutschland gmbh - calcii chloridum dihydricum,natrii hydrogenocarbonas,natrii chloridum,glucosum monohydricum,magnesii chloridum hexahydricum - peritoneaalidialyysineste - hypertoniset liuokset

Bicavera 1.5 % Glukoosi, 1.25 Mmol/L Kalsium 1,5 % glukoosi, 1,25 mmol/l kalsium peritoneaalidialyysineste Finska - finščina - Fimea (Suomen lääkevirasto)

bicavera 1.5 % glukoosi, 1.25 mmol/l kalsium 1,5 % glukoosi, 1,25 mmol/l kalsium peritoneaalidialyysineste

fresenius medical care deutschland gmbh - calcium chloride dihydrate, magnesium chloride hexahydrate, glucose monohydrate, sodium chloride - peritoneaalidialyysineste - 1,5 % glukoosi, 1,25 mmol/l kalsium - hypertoniset liuokset